About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT00847990

Non-Invasive Screening for Fetal Aneuploidy

The purpose of this study is to determine if a laboratory test developed by the Sequenom Center for Molecular Medicine (SCMM) that uses a new marker found in the mother's blood can better identify pre...

Lead sponsor: Sequenom, Inc.•25 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Sequenom, Inc.

Collaborators

Obstetrix

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Subject is willing to provide written informed consent
•Pregnant female with singleton gestation 18 years of age or older
•Subject agrees to provide a 20 to 30 mL venous blood sample
•Subject is one of the following: A) currently scheduled to undergo an amniocentesis and/or CVS procedure, OR B) currently in the first trimester of pregnancy and planning to undergo an amniocentesis in the second trimester
•Subject will receive results of a genetic analysis that includes evaluation of the fetus for aneuploidy

Exclusion Criteria

•Subject lacks the capacity to provide informed consent
•Twins, triplets or other multiple gestation

Related studies

RECRUITINGPhase 1/2

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

NCT04726241 · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and more

HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down Syndrome

NCT07296861 · Down Syndrome, Child Obesity

Retinal Imaging in Neurodegenerative Disease

NCT03233646 · Alzheimer's Disease, Mild Cognitive Impairment, and more

Immune Profile and Respiratory Parameters in Down Syndrome Children With Acute Pneumonia: Pre-Intervention Analysis

NCT07366593 · Down Syndrome

Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Muscle Strength, and Body Composition in Individuals With Down Syndrome

NCT07213063 · Down Syndrome (DS), Supplementation

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 5, 2011Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment5,000

Start dateMar 2009

Last updatedSep 5, 2011

Condition

Down Syndrome Edwards Syndrome

Locations shown

Desert Good Samaritan Hospital

Mesa, Arizona

Banner Good Samaritan Hospital

Phoenix, Arizona

Phoenix Perinatal Associates, Phoenix Arizona Clinic

Phoenix, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 5, 2011Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions